| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.0096 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0066 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.0099 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |